Related Experiment Video
Updated: Dec 31, 2025

05:35
Immunofluorescence Analysis of Endogenous and Exogenous Centromere-kinetochore Proteins
Published on: March 3, 2016
15.6K
Cullin 3 and Its Role in Tumorigenesis
1Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan. rhchen@gate.sinica.edu.tw.
Advances in Experimental Medicine and Biology
|January 4, 2020
Summary
Cullin 3 (Cul3) ubiquitin ligases, crucial for diverse cellular functions, are increasingly implicated in cancer. Understanding their roles and substrate adaptors is key to developing new cancer therapies.
Area of Science:
- Biochemistry and Molecular Biology
- Cancer Biology
- Cellular Regulation
Background:
- Cullin 3 (Cul3) ubiquitin ligases are multi-component complexes essential for protein degradation.
- They consist of RBX1, Cul3 scaffold, and a substrate-specific Bric-a-brac/Tramtrack/Broad complex (BTB) protein adaptor.
- The ~180 human BTB proteins suggest a wide range of ubiquitination targets and cellular roles.
Purpose of the Study:
- To review recent advances on the role of Cul3 E3 ligase complexes in cancer hallmarks and therapeutic responses.
- To discuss the implications of mutations and dysregulation of Cul3 substrate adaptors in tumorigenesis.
- To highlight specific Cul3 adaptors (Keap1, SPOP, KLHL20, LZTR1) and their functions in cancer.
Main Methods:
- Literature review and synthesis of existing research on Cul3 E3 ligases in cancer.
- Analysis of the roles of specific Cul3 substrate adaptors in oncogenesis and tumor suppression.
- Discussion of therapeutic strategies targeting Cul3 complexes.
Main Results:
- Cul3 ubiquitin ligases are involved in fundamental cellular processes like cell division, differentiation, and stress responses.
- Emerging evidence highlights their significant role in regulating cancer hallmarks.
- Dysregulation of Cul3 adaptors like Keap1, SPOP, KLHL20, and LZTR1 is linked to various cancers.
Conclusions:
- Cul3 E3 ligase complexes are master regulators of human malignancies.
- Targeting oncogenic or tumor-suppressive Cul3 complexes holds therapeutic potential for cancer intervention.
- Further research into Cul3 adaptors is crucial for developing novel cancer treatments.
More Related Videos
Related Concept Videos
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
mTOR Signaling and Cancer Progression
4.5K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.5K
Cancer-Critical Genes I: Proto-oncogenes
11.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
Loss of Tumor Suppressor Gene Functions
5.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K

